Skip to content
lifestyle.xbode.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
VALNEVA SE
Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
November 4, 2026
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
October 14, 2026
Valneva Provides Update on IXCHIQ® in the United Kingdom
October 7, 2026
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
August 14, 2026
Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates
August 13, 2026
Valneva Announces Successful Outcome of its Annual General Meeting
June 25, 2026